Key Details
Price
$52.90Annual ROE
-24.65%Beta
1.77Events Calendar
Next earnings date:
Feb 07, 2025Recent quarterly earnings:
Oct 23, 2024Recent annual earnings:
Feb 07, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Viking Therapeutics Inc. (VKTX) is approaching an important point as its stock price is just above a possible death cross.
Viking Therapeutics (VKTX 2.04%) is a hot biotech stock thanks to the company's record of reporting good data from its cardiometabolic disease programs, and there's no sign of that reputation being tarnished.
NEW YORK, NY / ACCESSWIRE / November 26, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Viking Therapeutics, Inc. ("Viking" or the "Company") (NASDAQ:VKTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK , Nov. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Viking Therapeutics, Inc. ("Viking" or the "Company") (NASDAQ: VKTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Ken Griffin started the Citadel hedge fund in 1990. It's become so successful that his net worth has risen to a stunning $46 billion.
Viking Therapeutics (VKTX) reported earnings 30 days ago. What's next for the stock?
NEW YORK, NY / ACCESSWIRE / November 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viking Therapeutics, Inc. ("Viking Therapeutics, Inc.") (NASDAQ:VKTX) concerning possible violations of federal securities laws. On November 3, 2024, Viking released positive trial data for VK2735, the Company's anti-obesity drug, as part of a presentation at the Obesity Week medical meeting, causing Viking's stock price to climb 9% during intraday trading on November 4, 2024.
The biotech's liver-disease treatment is also viewed as best-in-class, earning it a full slate of buy ratings from analysts.
3 Things You Need to Know if You Buy Viking Therapeutics Today
Is It Too Late to Buy Viking Therapeutics Stock?
FAQ
- What is the primary business of Viking Therapeutics?
- What is the ticker symbol for Viking Therapeutics?
- Does Viking Therapeutics pay dividends?
- What sector is Viking Therapeutics in?
- What industry is Viking Therapeutics in?
- What country is Viking Therapeutics based in?
- When did Viking Therapeutics go public?
- Is Viking Therapeutics in the S&P 500?
- Is Viking Therapeutics in the NASDAQ 100?
- Is Viking Therapeutics in the Dow Jones?
- When was Viking Therapeutics's last earnings report?
- When does Viking Therapeutics report earnings?
- Should I buy Viking Therapeutics stock now?